Abstract
The four-kallikrein panel and the Prostate Health Index (PHI) have been shown to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen (PSA). No comparison of the four-kallikrein panel and PHI has been presented.
Original language | English |
---|---|
Pages (from-to) | 139-146 |
Journal | European Urology |
Volume | 68 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2015 |
Subject classification (UKÄ)
- Clinical Medicine